大鼠嗜铬细胞分泌的膜电容和微碳纤电极检测

在原代培养的大鼠肾上腺嗜铬细胞上,综合运用细胞内钙测定法和全细胞膜片钳法,以检测膜电容变化为手段测定单一肾上腺嗜铬细胞的胞吐过程。－７０ｍＶ到＋２０ｍＶ去极化引起的钙电流和细胞膜电容的变化以及吹加６０ｍｍｏｌ／ＬＫＣｌ时,细胞内游离钙离子浓度［Ｃａ２＋］ｉ和细胞膜电容变化的同时检测,表明了Ｃａ２＋对细胞胞吐的控制作用。而用微碳纤电极则能检测到吹加６０ｍｍｏｌ／ＬＫＣｌ导致嗜铬细胞胞吐时儿茶酚胺的量子化释放。细胞膜电容检测和微碳纤电极检测从不同侧面动态的反映了细胞胞吐过程与Ｃａ２＋的相关性     

钙调蛋白及其结合蛋白对神经递质释放的调控作用

钙离子（Ca2+）是调节突触前神经递质的胞吐释放的关键离子信号.作为胞内最普遍存在的钙离子感受器的钙调蛋白（CaM）被发现能通过与多种蛋白的相互作用,调控着突触小泡的生发、运输及再填充,从而传递胞内Ca2+浓度变化的信号,对神经递质的释放及突触电生理活动起到至关重要的调控作用.本文综述了CaM及其结合蛋白是如何参与对突触小泡的胞吐释放和胞吞恢复的调控,并探讨了其中可能的分子机制.     

Ca2+依赖和Ca2+不依赖的囊泡分泌研究进展

Ca2 是促发囊泡胞吐的关键调节因子.最近的研究表明,分泌囊泡和通道之间的空间距离调节囊泡分泌的过程和性质.Ca2 通道开口附近形成的Ca2 微区和Ca2 钠区和囊泡快速递质释放有非常紧密的联系.SNARE蛋白和钙离子传感器synaptotagmins等在触发分泌中起调控作用.同时另有一类不依赖于Ca2 的囊泡分泌存在.Latrotoxin和mastoparan等可以激活这一类不依赖于Ca2 的信号通路,从而触发囊泡释放.本文主要从ca2 对囊泡胞吐的调控作用着手,综述了Ca2 依赖和Ca2 不依赖的囊泡分泌过程和可能的调控机制.     

FKBP38肝脏特异敲除小鼠模型的构建

目的:构建FKBP38(FK506 Binding Protein 38)基因肝脏特异敲除小鼠。方法:利用胚胎注射法构建在FKBP38上携带lox P位点的转基因小鼠。在FKBP38基因位置携带lox P位点的小鼠的基础上,以肝脏实质细胞特异性表达的Alb-Cre介导FKBP38条件性敲除,以获得FKBP38基因肝脏特异敲除小鼠模型Alb-Cre:FKBP38~(fl/fl)。同时对FKBP38特异性敲除鼠进行鉴定。结果:(1)FKBP38肝脏特异敲除小鼠FKBP38~(-/-)肝脏中FKBP38基因的m RNA水平相对于同年龄同窝野生型小鼠具有统计学差异(P0.001)。(2)FKBP38肝脏特异敲除小鼠FKBP38~(-/-)肝脏中FKBP38基因的蛋白表达水平相对于同年龄同窝野生型小鼠具有统计学差异(P0.001)。(3)FKBP38肝脏特异敲除小鼠FKBP38~(-/-)肝脏中,转录和翻译相关蛋白水平未见显著差异,p70 S6K的磷酸化水平轻微上调,4EBP-1的磷酸化水平有轻微下调。(4)FKBP38肝脏特异敲除小鼠FKBP38~(-/-)肝脏中,凋亡相关蛋白Bcl-2未见差异化表达。结论:FKBP38肝脏特异敲除小鼠FKBP38~(-/-)肝脏中,FKBP38基因的m RNA和蛋白基本不表达,提示成功构建FKBP38基因肝脏特异敲除小鼠。     

Ca^2＋依赖和Ca^2＋不依赖的囊泡分泌研究进展

Ca^2＋是促发囊泡胞吐的关键调节因子。最近的研究表明,分泌囊泡和通道之间的空间距离调节囊泡分泌的过程和挂质。Ca^2＋通道开口附近形成的Ca^2＋微区和Ca^2＋钠区和囊泡快速递质释放有非常紧密的联系。SNARE蛋白和钙离子传感器synaptotagmins等在触发分泌中起调控作用。同时另有一类不依赖于Ca^2＋的囊泡分泌存在。Latrotoxin和mastoparan等可以激活这一类不依赖于Ca^2＋的信号通路,从而触发囊泡释放。本文主要从Ca^2＋对囊泡胞吐的调控作用着手,综述了Ca^2＋依赖和Ca^2＋不依赖的囊泡分泌过程和可能的调控机制。     

胰岛素分泌及调节的分子机制

胰岛素是机体最重要的激素之一,它调节机体的血糖稳定、促进同化代谢、调节细胞的分裂分化和生长发育.胰岛β细胞的胰岛素分泌受到营养物质、神经递质和激素的精确调控.它们的作用部位可分为改变胞内第二信使物质水平的近端调节步骤（钙依赖性）,和直接作用于胞吐分子构件的末端调节步骤（钙非依赖性）.胰岛素的胞吐过程与神经递质的释放机制类似.葡萄糖等营养物质主要通过升高胞内的ATP/ADP比率,导致ATP敏感钾通道关闭、细胞膜去极化、钙内流这一途径增加胰岛素的分泌.神经递质和部分激素通过其G蛋白偶联受体-G蛋白系统的跨膜信号转换后,影响胞内IP₃、DAG、Ca²⁺等第二信使物质水平,主要通过PKA、PKC等蛋白激酶途径,调节胰岛素的分泌.胞内单体G蛋白参与了对囊泡运输和胞吐过程的调控,G蛋白也可能直接作用于胞吐过程,在分泌过程中发挥了重要的调节作用.     

钙离子:进入细胞浆的途径与血管平滑肌收缩机制

血管平滑肌收缩所需的钙离子源于细胞外流入和细胞内释放。钙流入途径主要有膜电位依赖式和与受体耦联的钙通道。释放钙离子机制受除极IP_3、cIP_3和钙离子作用而激发。进入细胞浆的钙离子与钙受体蛋白结合而引起收缩。血管平滑肌没有肌钙蛋白C,由钙调蛋白或Leiotonin C代之。钙调蛋白通过使肌球蛋白磷酸化;而Leiotonin C则通过直接激活肌动蛋白,引起血管收缩。     

钙离子在内毒素引起大鼠脊髓降钙素基因相关肽(CGRP)释放中的作用

实验在离体大鼠脊髓观察钙离子在内毒素引起CGRP释放中的作用,结果显示,内毒素和咖啡因可分别引起大鼠脊髓浓度依赖性地释放CGRP,但两者作用无叠加.应用辣椒素,无Ca ²⁺Krebs液,ω-Conotoxin,W-7,Ryanodine,MgCl₂,Tris-ATP,钌红等药物表明:内毒素引起感觉神经中枢端末梢释放CGRP,这一作用依赖于细胞外Ca ²⁺的存在,Ca ²⁺主要通过N型钙通道进入细胞后,与钙调蛋白结合,激活对咖啡因敏感,对Ryanodine不敏感的细胞内钙诱导的钙池Ca ²⁺释放,从而引起CGRP的释放.     

FKBP52对小鼠前列腺发育的影响

目的通过FKBP52基因敲除小鼠模型探索FKBP52在小鼠前列腺发育过程中的作用。方法分别对胚胎第17．5天、新生的和出生后3周的野生型和FKBP52基因敲除小鼠的前列腺进行切片HE染色,观察不同发育时期里野生型和FKBP52基因敲除小鼠前列腺发育的异同。结果（1）小鼠前列腺发育的起始不依赖于FKBP52基因的参与;（2）随着胚胎的发育,FKBP52在雄鼠前列腺发育中的作用逐渐显现出来,即FKBP52的缺失会导致前列腺叶发育受阻,最终不能形成成熟的前列腺。结论FKBP52在小鼠前列腺的发育过程中具有重要作用,它不参与前列腺的发育起始过程,但其缺失会导致前列腺发育受阻,即不能形成成熟的前列腺。     

Synaptotagmin蛋白的基本机制及在细胞分泌中的作用

囊泡的转运和融合涉及多个步骤和复杂的蛋白质相互作用.而其中突触结合蛋白(Syrmptotagmin,Syt)是一个广泛存在于神经和内分泌细胞内的分泌囊泡上的蛋白质家族.作为钙离子依赖性神经递质和激素释放过程中的钙离子感受器,Syt触发和调节囊泡与靶膜的融合过程,参与对神经递质和激素释放过程的严格调控,也可能参与对细胞的蛋白质与膜转运的调节.该家族在哺乳动物中有16种以上的亚型,它们在细胞内有各自不同的定位,并发挥不同的调节功能.通过亚型问以及亚型和效应物分子闻的相互作用,特别是对钙离子的结合,Syt对胞吐过程进行着有效地调控.在膜融合的事件中,大部分是需要钙离子的存在的.Syt可能是一种在较为宽广范围的膜融合事件中广泛分布的钙离子敏感的融合机制中的调控蛋白.本文主要对Syt蛋白质家族的分类以及各种亚型在细胞分泌中的功能和定位进行综合性阐述.     

CaV1.3 as pacemaker channels in adrenal chromaffin cells: Specific role on exo- and endocytosis?

Voltage-gated L-type calcium channels (LTCCs) are expressed in adrenal chromaffin cells. Besides shaping the action potential (AP), LTCCs are involved in the excitation-secretion coupling controlling catecholamine release and in Ca²⁺-dependent vesicle retrieval. Of the two LTCCs expressed in chromaffin cells (Ca_V1.2 and Ca_V1.3), Ca_V1.3 possesses the prerequisites for pacemaking spontaneously firing cells: low-threshold, steep voltage-dependence of activation and slow inactivation. By using Ca_V1 .3^-/- KO mice and the AP-clamp it has been possible to resolve the time course of Ca_V1.3 pacemaker currents, which is similar to that regulating substantia nigra dopaminergic neurons. In mouse chromaffin cells Ca_V1.3 is coupled to fast-inactivating BK channels within membrane nanodomains and controls AP repolarization. The ability to carry subthreshold Ca²⁺ currents and activate BK channels confers to Ca_V1.3 the unique feature of driving Ca²⁺ loading during long interspike intervals and, possibly, to control the Ca²⁺-dependent exocytosis and endocytosis processes that regulate catecholamine secretion and vesicle recycling.     

FKBP12.6 disruption impairs glucose-induced insulin secretion

Cyclic ADP-ribose (cADPR), accumulated in pancreatic β-cells in response to elevated ATP levels after glucose stimulation, mobilizes Ca²⁺ from the endoplasmic reticulum through the ryanodine receptor (RyR) and thereby induces insulin secretion. We have recently demonstrated in an in vitro study that cADPR activates RyR through binding to FK506-binding protein 12.6 (FKBP12.6), an accessory protein of RyR. Here we generated FKBP12.6-deficient (FKBP12.6^−/−) mice by homologous recombination. FKBP12.6^−/− mice showed glucose intolerance coupled to insufficient insulin secretion upon a glucose challenge. Insulin secretion in response to glucose was markedly impaired in FKBP12.6^−/− islets, while sulfonylurea- or KCl-induced insulin secretion was unaffected. No difference was found in the glucose oxidation rate between FKBP12.6^−/− and wild-type islets. These results indicate that FKBP12.6 plays a role in glucose-induced insulin secretion downstream of ATP production, independently of ATP-sensitive K⁺ channels, in pancreatic β-cells.     

Catecholamine secretion by hamster adrenal cells.

Abstract— Suspensions of isolated adrenal cells were prepared by digesting hamster adrenal glands with collagenase, and the secretion of catecholamine from these cells was studied. Acetylcholine (ACh) produces a dose-dependent increase in catecholamine secretion; half-maximal secretion is produced by 3 μm -ACh, and maximal secretion by 100 μm -ACh. The cholinergic receptor in these cells appears to be nicotinic, since catecholamine secretion is stimulated by the nicotinic agonists nicotine and dimeth-ylphenylpiperaziniurn, but not by the muscarinic agonists pilocarpine or oxotremorine. ACh-induced catecholamine secretion is inhibited by hexamethonium, tubocurarine, and atropine, but is not inhibited by α-bungarotoxin. ACh-induced catecholamine secretion is dependent upon the presence of extracellular Ca²⁺, and appears to occur by exocytosis, since the release of catecholamine is accompanied by the release of dopamine β-monooxygenase, but not of lactate dehydrogenase. These biochemical studies complement the morphological evidence for exocytosis in hamster adrenal glands, and indicate that catecholamine secretion from hamster chromaffin cells is similar to that from chromaffin cells of other species.     

FKBP12.6 protects heart from AngII‐induced hypertrophy through inhibiting Ca2+/calmodulin‐mediated signalling pathways in vivo and in vitro

We previously observed that disruption of FK506‐binding protein 12.6 (FKBP12.6) gene resulted in cardiac hypertrophy in male mice. Studies showed that overexpression of FKBP12.6 attenuated thoracic aortic constriction (TAC)‐induced cardiac hypertrophy in mice, whereas the adenovirus‐mediated overexpression of FKBP12.6 induced hypertrophy and apoptosis in cultured neonatal cardiomyocytes, indicating that the role of FKBP12.6 in cardiac hypertrophy is still controversial. In this study, we aimed to investigate the roles and mechanisms of FKBP12.6 in angiotensin II (AngII)‐induced cardiac hypertrophy using various transgenic mouse models in vivo and in vitro. FKBP12.6 knockout (FKBP12.6^?/?) mice and cardiac‐specific FKBP12.6 overexpressing (FKBP12.6 TG) mice were infused with AngII (1500 ng/kg/min) for 14 days subcutaneously by implantation of an osmotic mini‐pump. The results showed that FKBP12.6 deficiency aggravated AngII‐induced cardiac hypertrophy, while cardiac‐specific overexpression of FKBP12.6 prevented hearts from the hypertrophic response to AngII stimulation in mice. Consistent with the results in vivo, overexpression of FKBP12.6 in H9c2 cells significantly repressed the AngII‐induced cardiomyocyte hypertrophy, seen as reductions in the cell sizes and the expressions of hypertrophic genes. Furthermore, we demonstrated that the protection of FKBP12.6 on AngII‐induced cardiac hypertrophy was involved in reducing the concentration of intracellular Ca²⁺ ([Ca²⁺]i), in which the protein significantly inhibited the key Ca²⁺/calmodulin‐dependent signalling pathways such as calcineurin/cardiac form of nuclear factor of activated T cells 4 (NFATc4), calmodulin kinaseII (CaMKII)/MEF‐2, AKT/Glycogen synthase kinase 3β (GSK3β)/NFATc4 and AKT/mTOR signalling pathways. Our study demonstrated that FKBP12.6 protects heart from AngII‐induced cardiac hypertrophy through inhibiting Ca²⁺/calmodulin‐mediated signalling pathways.     

Extracellular Caper se inhibits quantal size of catecholamine release in adrenal slice chromaffin cells

Classic calcium hypothesis states that depolarization-induced increase in intracellular Ca²⁺ concentration ([Ca²⁺]_i) triggers vesicle exocytosis by increasing vesicle release probability in neurons and neuroendocrine cells. The extracellular Ca²⁺, in this calcium hypothesis, serves as a reservoir of Ca²⁺ source. Recently we find that extracellular Ca²⁺per se inhibits the [Ca²⁺]_i dependent vesicle exocytosis, but it remains unclear whether quantal size is regulated by extracellular, or intracellular Ca²⁺ or both [1]. In this work we showed that, in physiological condition, extracellular Ca²⁺per se specifically inhibited the quantal size of single vesicle release in rat adrenal slice chromaffin cells. The extracellular Ca²⁺ in physiological concentration (2.5 mM) directly regulated fusion pore kinetics of spontaneous quantal release of catecholamine. In addition, removal of extracellular Ca²⁺ directly triggered vesicle exocytosis without eliciting intracellular Ca²⁺. We propose that intracellular Ca²⁺ and extracellular Ca²⁺per se cooperately regulate single vesicle exocytosis. The vesicle release probability was jointly modulated by both intracellular and extracellular Ca²⁺, while the vesicle quantal size was mainly determined by extracellular Ca²⁺ in chromaffin cells physiologically.     

Roles for Protein Kinase C and Mitogen-Activated Protein Kinase in Nicotine-Induced Secretion from Bovine Adrenal Chromaffin Cells

Abstract: Both the Ca²⁺/phospholipid-dependent protein kinases (protein kinases C, PKCs) and mitogen-activated protein kinases (MAPKs) have been implicated as participants in the secretory response of bovine adrenomedullary chromaffin cells. To investigate a possible role for these kinases in exocytosis and the relationship of these kinases to one another, intact chromaffin cells were treated with agents that inhibited each of the kinases and analyzed for catecholamine release and MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK)/MAPK activation after stimulation with secretagogues of differential efficacy. Of the three secretagogues tested, inactivation of PKCs by long-term phorbol 12-myristate 13-acetate (PMA) treatment or incubation with GF109203X had the greatest inhibitory effect on nicotine-induced catecholamine release and MEK/MAPK activation, a moderate effect on KCl-induced events, and little, if any, effect on Ca²⁺ ionophore-elicited exocytosis and MEK/MAPK activation. These results indicate that PKC plays a significant role in events induced by the optimal secretagogue nicotine and a lesser role in exocytosis elicited by the suboptimal secretagogues KCl and Ca²⁺ ionophore. Treatment of cells with the MEK-activation inhibitor PD098059 completely inhibited MEK/MAPK activation (IC₅₀ 1–5 µM) and partially inhibited catecholamine release induced by all secretagogues. However, PD098059 was more effective at inhibiting exocytosis induced by suboptimal secretagogues (IC₅₀～10 µM) than that induced by nicotine (IC₅₀～30 µM). These results suggest a more prominent role for MEK/MAPK in basic secretory events activated by suboptimal secretagogues than in those activated by the optimal secretagogue nicotine. However, PD098059 also partially blocked secretion potentiated by short-term PMA treatment, suggesting that PKC can function in part by signaling through MEK/MAPK to enhance secretion. Taken together, these results provide evidence for the preferential involvement of MEK/MAPK in basic secretory events activated by the suboptimal secretagogues KCl and Ca²⁺ ionophore and the participation of both PKC and MEK/MAPK in optimal secretion induced by nicotine.     

Inhibition of Ca<Superscript>2+</Superscript> Channels and Adrenal Catecholamine Release by G Protein Coupled Receptors

Catecholamines and other transmitters released from adrenal chromaffin cells play central roles in the “fight-or-flight” response and exert profound effects on cardiovascular, endocrine, immune, and nervous system function. As such, precise regulation of chromaffin cell exocytosis is key to maintaining normal physiological function and appropriate responsiveness to acute stress. Chromaffin cells express a number of different G protein coupled receptors (GPCRs) that sense the local environment and orchestrate this precise control of transmitter release. The primary trigger for catecholamine release is Ca²⁺ entry through voltage-gated Ca²⁺ channels, so it makes sense that these channels are subject to complex regulation by GPCRs. In particular G protein βγ heterodimers (Gβγ) bind to and inhibit Ca²⁺ channels. Here I review the mechanisms by which GPCRs inhibit Ca²⁺ channels in chromaffin cells and how this might be altered by cellular context. This is related to the potent autocrine inhibition of Ca²⁺ entry and transmitter release seen in chromaffin cells. Recent data that implicate an additional inhibitory target of Gβγ on the exocytotic machinery and how this might fine tune neuroendocrine secretion are also discussed.     

The relationship between secretion and intracellular free calcium in bovine adrenal chromaffin cells

The effect of carbamylcholine and the calcium ionophore A23187 on catecholamine release and intracellular free calcium, [Ca²⁺]i, in bovine adrenal chromaffin cells was determined. At 10^–4M carbamylcholine maximal release occurred with an accompanying increase i n [Ca²⁺]i from a basal level of 168 nM to less than 300 nM. An increase in [Ca²⁺]i of a similar magnitude was found following challenge with 40 nM A23187. However, in this case, no catecholamine release occurred. These results suggest that stimulation of secretion from chromaffin cells by carbamylcholine may involve additional triggers which stimulate secretion at low [Ca²⁺]i.     

Effect of calmidazolium and phorbol ester on catecholamine secretion from adrenal chromaffin cells

Carbamylcholine-stimulated catecholamine release from adrenal chromaffin cells was completely inhibited by pretreatment of the cells for 10 min with 1 μM calmidazolium. Catecholamine release due to 55 mM K⁺ and ionophore A23187 was also inhibited by calmidazolium but less effectively than release due to carbamylcholine. Inhibition of release appeared to be due to an effect of calmidazolium on a step distal to Ca²⁺ entry, since the carbamylcholine-stimulated rise in the concentration of intracellular free calcium, monitored using quin-2, was unaffected by calmidazolium. The possibility was considered that calmidazolium inhibited secretion through an effect on protein kinase C rather than calmodulin. However, the phorbol ester, 12-O-tetradecanoylphorbol 13-acetate (TPA), had no demonstrable effect on catecholamine release, arguing against a significant role for protein kinase C in secretion from adrenal chromaffin cells. These results give further support to the notion that calmodulin plays a role in the secretory process in chromaffin cells.     

A two-step model for acetylcholine control of exocytosis via nicotinic receptors

The view that Ca²⁺ entry through voltage-dependent Ca²⁺ channels (VDCC) and through nicotinic receptors for acetylcholine (nAChRs) causes equal catecholamine release responses in chromaffin cells, was reinvestigated here using new protocols. We have made two-step experiments consisting in an ACh prepulse followed by a depolarizing pulse (DP). In voltage-clamped bovine chromaffin cells an ACh prepulse caused a slow-rate release but augmented 4.5-fold the much faster exocytotic response triggered by a subsequent depolarizing pulse (measured with capacitance and amperometry). If the ACh prepulse was given with mecamylamine or in low external Ca²⁺, the secretion increase disappeared. This suggests a two-step model for the effects of ACh: (1) meager Ca²⁺ entry through nAChRs mostly serves to keep loaded with vesicles the secretory machine; and (2) in this manner, the cell is prepared to respond with an explosive secretion of catecholamine upon depolarization and fast high Ca²⁺ entry through VDCC.